Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge

Vaccine

Volumn 26, Issue 15, 2008, Pages 1855-1862

  Chung, Yao Chi ^a   Ho, Mei Shang ^b   Wu, Jaw Chin ^c   Chen, Wei Jheng ^a   Huang, Jen Huang ^a   Chou, Szu Ting ^a   Hu, Yu Chen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Enterovirus 71; Immune responses; Immunization; Vaccine; Virus like particle

Indexed keywords

IMMUNOGLOBULIN G; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; LETHAL DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; VIRUS IMMUNITY; VIRUS LIKE AGENT; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; CELL PROLIFERATION; CHILD; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; SPLEEN; SURVIVAL ANALYSIS; T-LYMPHOCYTES; VACCINES, INACTIVATED; VACCINES, VIROSOME; VIRAL VACCINES;

EID: 40849137446     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.01.058     Document Type: Article

References (31)

1. McMinn P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26 (2002) 91-107
2. Ho M.T., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., et al. An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med 341 (1999) 929-935
3. Fujimoto T., Chikahira M., Yoshida S., Ebira H., Hasegawa A., Totsuka A., et al. Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol Immunol 46 (2002) 621-627
4. Singh S., Chow V.T.K., Phoon M.C., Chan K.P., and Poh C.L. Direct detection of enterovirus 71 (EV71) in clinical specimens from a hand, foot, and mouth disease outbreak in Singapore by reverse transcription-PCR with universal enterovirus and EV71-specific primers. J Clin Microbiol 40 (2002) 2823-2827
5. Wu C.N., Lin Y.C., Fann C., Liao N.S., Shih S.R., and Ho M.S. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20 (2001) 895-904
6. Boisgerault F., Moron G., and Leclerc C. Virus-like particles: a new family of delivery systems. Expert Rev Vaccines 1 (2002) 101-109
7. Ramqvist T., Andreasson K., and Dalianis T. Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer. Expert Opin Biol Ther 7 (2007) 997-1007
8. Young K.R., McBurney S.P., Karkhanis L.U., and Ross T.M. Virus-like particles: designing an effective AIDS vaccine. Methods 40 (2006) 98-117
9. Grgacic E.V., and Anderson D.A. Virus-like particles: passport to immune recognition. Methods 40 (2006) 60-65
10. Hu Y.-C., Hsu T.-A., Huang J.-H., Ho M.-S., and Ho Y.-C. Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells. Biotechnol Lett 25 (2003) 919-925
11. Chung Y.-C., Huang J.-H., Lai C.-W., Sheng H.-C., Shih S.-R., Ho M.-S., et al. Expression, purification and characterization of enterovirus 71 virus-like particles. World J Gastroenterol 12 (2006) 921-927
12. Lin Y.C., Wu C.N., Shih S.R., and Ho M.S. Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. Vaccine 20 (2002) 2485-2493
13. Shih S.R., Li Y.S., Chiou C.C., Suen P.C., Lin T.Y., Chang L.Y., et al. Expression of caspid protein VP1 for use as antigen for the diagnosis of enterovirus 71 infection. J Med Virol 61 (2000) 228-234
14. Reed L.J., and Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 27 (1938) 493-497
15. Melnick J.L., and Wimberly I.L. Lyophilized combination pools of enterovirus equine antisera: new LBM pools prepared from reserves of antisera stored frozen for two decades. Bull World Health Organ 63 (1985) 543-550
16. Lenz P., Day P.M., Pang Y.Y.S., Frye S.A., Jensen P.N., Lowy D.R., et al. Papillomavirus-like particles induce acute activation of dendritic cells. J Immunol 166 (2001) 5346-5355
17. Gamvrellis A., Leong D., Hanley J.C., Xiang S.D., Mottram P., and Plebanski M. Vaccines that facilitate antigen entry into dendritic cells. Immunol Cell Biol 82 (2004) 506-516
18. Lo-Man R., Rueda P., Sedlik C., Deriaud E., Casal I., and Leclerc C. A recombinant virus-like particle system derived from parvovirus as an efficient antigen carrier to elicit a polarized Th1 immune response without adjuvant. Eur J Immunol 28 (1998) 1401-1407
19. Roth J.F. The yeast Ty virus-like particles. Yeast 16 (2000) 785-795
20. Schiller J.T., and Lowy D.R. Papillomavirus-like particles and HPV vaccine development. Semi Cancer Biol 7 (1996) 373-382
21. Quan F.-S., Huang C., Compans R.W., and Kang S.-M. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol 81 (2007) 3514-3524
22. Emeny R.T., Wheeler C.M., Jansen K.U., Hunt W.C., Fu T.M., Smith J.F., et al. Priming of human papillomavirus type 11-specific humoral and cellular immune responses in collage-aged women with a virus-like particle vaccine. J Virol 76 (2002) 7832-7842
23. Muir P., Kammerer U., Korn K., Mulders M.N., Poyry T., Weissbrich B., et al. Molecular typing of enteroviruses: current status and future requirements. Clin Microbiol Rev 11 (1998) 202-227
24. Denis J., Majeau N., Acosta-Ramirez E., Savard C., Bedard M.C., Simard S., et al. Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization. Virology 363 (2007) 59-68
25. Zinkernagel R.M. On natural and artificial vaccinations. Annu Rev Immunol 21 (2003) 515-546
26. Foo D.G., Alonso S., Phoon M.C., Ramachandran N.P., Chow V.T., and Poh C.L. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res 125 (2007) 61-68
27. Hogle J.M., Chow M., and Filman D.J. Three-dimensional structure of poliovirus at 2.9 A resolution. Science 229 (1985) 1358-1365
28. Rossmann M.G., Arnold E., Erickson J.W., Frankenberger E.A., Griffith J.P., Hecht H.J., et al. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317 (1985) 145-153
29. Muckelbauer J.K., Kremer M., Minor I., Tong L., Zlotnick A., Johnson J.E., et al. Structure determination of coxsackievirus B3 to 3.5 A resolution. Acta Crystallogr D Biol Crystallogr 51 (1995) 871-887
30. Chiu C.H., Chu C.S., He C.C., and Lin T.Y. Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microb Infect 8 (2006) 1671-1678
31. Chen H.F., Chang M.H., Chiang B.L., and Jeng S.T. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine 24 (2006) 2944-2951